Source: International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Usmani (London, United Kingdom). Monitoring asthma - state-of-the-art physiological, imaging and biomarker assessments. International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease

Member's Comments

No comment yet.

Related content which might interest you: Monitoring asthma – state-of-the-art physiological, imaging, and biomarker assessments Source: International Congress 2015 – PG2 Asthma and COPD Year: 2015 Monitoring asthma: state-of-the-art physiological, imaging, and biomarker assessments Source: International Congress 2016 – PG1 Asthma and chronic obstructive pulmonary disease Year: 2016 COPD biomarkers and phenotypes: opportunities for better outcomes with precision imaging Source: Eur Respir J, 52 (5) 1801570; 10.1183/13993003.01570-2018 Year: 2018 Functional Respiratory Imaging as a sensitive biomarker to assess therapeutic interventions in lung diseases Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles Year: 2015 Diagnostics of impaired lung function in asthmatics by MSCT-volumetry Source: International Congress 2014 – Functional imaging Year: 2014 LATE-BREAKING ABSTRACT: Evaluating dynamic oxygen-enhanced MRI biomarkers of lung function: Sensitivity to conventional COPD treatment Source: Annual Congress 2013 –Functional imaging Year: 2013 Monitoring asthma in children: clinical tools Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force Year: 2014 Clinical prediction guides in COPD, a real life evaluation Source: International Congress 2019 – Clinical implications of COPD management Year: 2019 Serial FEV1 measurements: an improved diagnostic tool for occupational asthma? Source: International Congress 2017 – Asthma: clinical and epidemiologic characterisation Year: 2017 Are FENO indices useful diagnostic tools in suspected asthma? Experience of a routine lung function laboratory Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 COPD and hypogonadism Source: International Congress 2014 – Pathophysiological mechanisms at different scales Year: 2014 Role of biomarkers in the assessment and phenotyping asthma and COPD Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 An automated application for analysis of incremental exercise tests Source: International Congress 2014 – Clinical exercise physiology in health and COPD Year: 2014 A network-based approach to defining phenotypes in COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Exercise-induced bronchoconstriction in a school-age cohort: Prevalence, risk factors and utility of the Cooper test for its routine detection Source: International Congress 2014 – Alterations of exercise and lung function in different diseases Year: 2014 A new tool for lung imaging: vibration response imaging (VRI). Experience in a paediatric population Source: Annual Congress 2009 - Diagnostic tools in paediatric respiratory infection Year: 2009 What the radiologist can offer - the latest imaging and evaluation techniques for lung cancer screening and comorbidities Source: International Congress 2018 – Lung cancer screening and management of solitary pulmonary nodules Year: 2018